Mettler-Toledo International (NYSE:MTD – Get Free Report) and Stevanato Group (NYSE:STVN – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.
Profitability
This table compares Mettler-Toledo International and Stevanato Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mettler-Toledo International | 22.25% | 15,012.71% | 25.41% |
| Stevanato Group | 11.24% | 10.51% | 6.22% |
Earnings and Valuation
This table compares Mettler-Toledo International and Stevanato Group”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mettler-Toledo International | $4.20 billion | 8.08 | $869.19 million | $46.15 | 36.95 |
| Stevanato Group | $1.25 billion | 3.85 | $158.21 million | €0.58 | 27.33 |
Mettler-Toledo International has higher revenue and earnings than Stevanato Group. Stevanato Group is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Mettler-Toledo International has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500.
Institutional & Insider Ownership
95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by insiders. Comparatively, 0.7% of Stevanato Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and target prices for Mettler-Toledo International and Stevanato Group, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mettler-Toledo International | 1 | 8 | 6 | 0 | 2.33 |
| Stevanato Group | 0 | 5 | 2 | 2 | 2.67 |
Mettler-Toledo International currently has a consensus price target of $1,595.77, suggesting a potential downside of 6.41%. Given Mettler-Toledo International’s higher possible upside, equities research analysts clearly believe Mettler-Toledo International is more favorable than Stevanato Group.
Summary
Mettler-Toledo International beats Stevanato Group on 13 of the 15 factors compared between the two stocks.
About Mettler-Toledo International
Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes. The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.
About Stevanato Group
Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
